Epic Sciences wins federal grant to develop lung cancer test

01/25/2013 | GenomeWeb Daily News (free registration)

The NIH and the National Cancer Institute awarded Epic Sciences a Small Business Innovation Research grant to develop a test to detect and specify circulating tumor cells in lung cancer patients. Epic previously won a Phase I grant. The grants total $1.2 million.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI